Extend Survival News Today

Sangamo Therapeutics : Engineered Zinc Finger Transcriptional Regulators Specifically Reduce Prion Expression and Extend Survival in an Aggressive Prion Disease Model

May 22, 2023

Engineered Zinc Finger Transcriptional Regulators Specifically Reduce Prion Expression and Extend Survival in an Aggressive Prion Disease Model ... | May 22, 2023

Sangamo Therapeutics, Inc.: Sangamo Therapeutics to Present Pre-clinical Data From Its Genomic Engineering Platform at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

May 2, 2023

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene Cell Therapy (ASGCT) has accepted 14 Sangamo abstracts for presentation at the

Louise Wilkie Jason Fontenot Los Angeles Platform Development For Production Administration In Cynomolgus Macaques Sangamo Therapeutics Inc

Source: finanznachrichten.de

Navigation

Extend Survival News Today

Sangamo Therapeutics : Engineered Zinc Finger Transcriptional Regulators Specifically Reduce Prion Expression and Extend Survival in an Aggressive Prion Disease Model

Sangamo Therapeutics, Inc.: Sangamo Therapeutics to Present Pre-clinical Data From Its Genomic Engineering Platform at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Explore More Categories